Centre for Primary Care Seminar Series seminar
|Dates:||5 November 2013|
|Times:||14:00 - 15:00|
|What is it:||Seminar|
|Organiser:||Institute of Population Health|
|Who is it for:||University staff|
Host: Institute of Population Health
Can more frequent HbA1c measurements be used to titrate diabetes medication?
Diabetes is a major and increasing health problem and maintaining good glycaemic control is crucial to good diabetes care. The recommended monitoring interval for HbA1c in type 2 diabetes is 3 to 6 months, but this is based on expert opinion. We carried out a 12-week cohort study to explore whether routine HbA1c testing intervals before 12 weeks has potential to inform diabetes medication adjustments following a medication change. HbA1c was measured at frequent time intervals in 79 patients with type 2 diabetes who had had a change in their oral diabetes medication. Results from this study will be presented and the value of measuring HbA1c at shorter time intervals in certain patients will be discussed.
Jenny Hirst, NIHR Doctoral Research Fellow, Department of Primary Care Health Sciences, University of Oxford
Travel and Contact Information
Seminar room 1, 5th floor